Project number: POIR.01.01.01-00-0129/18
Title: „Technology platform designed for the development and study of therapeutics used in cancer immunotherapy. Development of small molecules for the immune checkpoint blockade in combination cancer immunotherapies”.
Programme: Measure 1.1 – „R&D projects of enterprises”, Sub‑measure 1.1.1 – “Industrial research and development carried out by enterprises” of the Smart Growth Operational Programme 2014–2020 co-financed by the European Union from the European Regional Development Fund.
Project value [PLN]: 12 461 236.71
Contribution of EU Funds [PLN]: 9 404 996.12
Keywords: cancer, cancer immunotherapy, immune checkpoint receptors, PD-1, PD-L1, inhibitors, modulators